| 000 | 02779 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250518054851.0 | ||
| 264 | 0 | _c20200910 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-19-0508 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaird, Richard D | |
| 245 | 0 | 0 |
_aPOSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c11 2019 |
||
| 300 |
_a6598-6605 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aCirculating Tumor DNA |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOxazepines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xgenetics |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _avan Rossum, Annelot G J | |
| 700 | 1 | _aOliveira, Mafalda | |
| 700 | 1 | _aBeelen, Karin | |
| 700 | 1 | _aGao, Meiling | |
| 700 | 1 | _aSchrier, Mariette | |
| 700 | 1 | _aMandjes, Ingrid A M | |
| 700 | 1 | _aGarcia-Corbacho, Javier | |
| 700 | 1 | _aVallier, Anne-Laure | |
| 700 | 1 | _aDougall, Greig | |
| 700 | 1 | _avan Werkhoven, Erik | |
| 700 | 1 | _aLinossi, Constanza | |
| 700 | 1 | _aKumar, Sanjeev | |
| 700 | 1 | _avan Tinteren, Harm | |
| 700 | 1 | _aCallari, Maurizio | |
| 700 | 1 | _aBeddowes, Emma | |
| 700 | 1 | _aPerez-Garcia, José-Manuel | |
| 700 | 1 | _aRosing, Hilde | |
| 700 | 1 | _aPlatte, Else | |
| 700 | 1 | _aNederlof, Petra | |
| 700 | 1 | _aSchot, Margaret | |
| 700 | 1 | _ade Vries Schultink, Aurelia | |
| 700 | 1 | _aBernards, René | |
| 700 | 1 | _aSaura, Cristina | |
| 700 | 1 | _aGallagher, William | |
| 700 | 1 | _aCortès, Javier | |
| 700 | 1 | _aCaldas, Carlos | |
| 700 | 1 | _aLinn, Sabine C | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 25 _gno. 22 _gp. 6598-6605 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-19-0508 _zAvailable from publisher's website |
| 999 |
_c30031878 _d30031878 |
||